IXIARO
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for IXIARO, covering 2011-05-27 to 2023-05-25. Get the full timeline:
Most recent: EMA Authorised: Ixiaro (Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)) — Valneva Austria GmbH